These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB Grafinger KE; Cannaert A; Ametovski A; Sparkes E; Cairns E; Banister SD; Auwärter V; Stove CP Drug Test Anal; 2021 Jul; 13(7):1402-1411. PubMed ID: 33769699 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for 5F-MDMB-PICA and its 5F-pentylindole analogs to induce cannabinoid-like effects in mice. Glatfelter GC; Partilla JS; Baumann MH Neuropsychopharmacology; 2022 Mar; 47(4):924-932. PubMed ID: 34802041 [TBL] [Abstract][Full Text] [Related]
7. Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists. Sachdev S; Banister SD; Santiago M; Bladen C; Kassiou M; Connor M Pharmacol Res Perspect; 2020 Apr; 8(2):e00566. PubMed ID: 32101383 [TBL] [Abstract][Full Text] [Related]
8. Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor. Zagzoog A; Brandt AL; Black T; Kim ED; Burkart R; Patel M; Jin Z; Nikolaeva M; Laprairie RB Sci Rep; 2021 May; 11(1):10611. PubMed ID: 34012003 [TBL] [Abstract][Full Text] [Related]
9. Linking in vitro and ex vivo CB Janssens LK; Hudson S; Wood DM; Wolfe C; Dargan PI; Stove CP Arch Toxicol; 2022 Nov; 96(11):2935-2945. PubMed ID: 35962200 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and functional evaluation of proteinogenic amino acid-derived synthetic cannabinoid receptor agonists related to MPP-5F-PICA, MMB-5F-PICA, and MDMB-5F-PICA. Sparkes E; Markham JW; Boyd R; Udoh M; Gordon R; Zaman H; Walker KA; Dane C; Kevin RC; Santiago MJ; Hibbs DE; Banister SD; Ametovski A; Cairns EA RSC Med Chem; 2024 Jun; 15(6):2063-2079. PubMed ID: 38911147 [TBL] [Abstract][Full Text] [Related]
11. Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonists. Patel M; Manning JJ; Finlay DB; Javitch JA; Banister SD; Grimsey NL; Glass M Biochem Pharmacol; 2020 May; 175():113871. PubMed ID: 32088263 [TBL] [Abstract][Full Text] [Related]
12. Enantiospecific Synthesis, Chiral Separation, and Biological Activity of Four Indazole-3-Carboxamide-Type Synthetic Cannabinoid Receptor Agonists and Their Detection in Seized Drug Samples. Antonides LH; Cannaert A; Norman C; Vives L; Harrison A; Costello A; Nic Daeid N; Stove CP; Sutcliffe OB; McKenzie C Front Chem; 2019; 7():321. PubMed ID: 31157203 [TBL] [Abstract][Full Text] [Related]
13. Metabolites of Synthetic Cannabinoid 5F-MDMB-PINACA Retain Affinity, Act as High Efficacy Agonists and Exhibit Atypical Pharmacodynamic Properties at CB1 Receptors. Cabanlong CV; Russell LN; Fantegrossi WE; Prather PL Toxicol Sci; 2022 Apr; 187(1):175-185. PubMed ID: 35201352 [TBL] [Abstract][Full Text] [Related]
14. Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA. Gamage TF; Farquhar CE; Lefever TW; Marusich JA; Kevin RC; McGregor IS; Wiley JL; Thomas BF J Pharmacol Exp Ther; 2018 May; 365(2):437-446. PubMed ID: 29549157 [TBL] [Abstract][Full Text] [Related]
15. Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB Ryalls B; Patel M; Sparkes E; Banister SD; Finlay DB; Glass M Biochem Pharmacol; 2024 Apr; 222():116052. PubMed ID: 38354957 [TBL] [Abstract][Full Text] [Related]
16. Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB Patel M; Grimsey NL; Banister SD; Finlay DB; Glass M Pharmacol Res Perspect; 2023 Dec; 11(6):e01157. PubMed ID: 38018694 [TBL] [Abstract][Full Text] [Related]
17. Shape matters: The application of activity-based in vitro bioassays and chiral profiling to the pharmacological evaluation of synthetic cannabinoid receptor agonists in drug-infused papers seized in prisons. Antonides LH; Cannaert A; Norman C; NicDáeid N; Sutcliffe OB; Stove CP; McKenzie C Drug Test Anal; 2021 Mar; 13(3):628-643. PubMed ID: 33161649 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists. Patel M; Zheng X; Akinfiresoye LR; Prioleau C; Walker TD; Glass M; Marusich JA Eur J Pharmacol; 2024 May; 971():176549. PubMed ID: 38561104 [TBL] [Abstract][Full Text] [Related]
19. In vitro determination of the efficacy of illicit synthetic cannabinoids at CB Sachdev S; Vemuri K; Banister SD; Longworth M; Kassiou M; Santiago M; Makriyannis A; Connor M Br J Pharmacol; 2019 Dec; 176(24):4653-4665. PubMed ID: 31412133 [TBL] [Abstract][Full Text] [Related]
20. Exploring Stereochemical and Conformational Requirements at Cannabinoid Receptors for Synthetic Cannabinoids Related to SDB-006, 5F-SDB-006, CUMYL-PICA, and 5F-CUMYL-PICA. Ametovski A; Macdonald C; Manning JJ; Haneef SAS; Santiago M; Martin L; Sparkes E; Reckers A; Gerona RR; Connor M; Glass M; Banister SD ACS Chem Neurosci; 2020 Nov; 11(21):3672-3682. PubMed ID: 33054155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]